Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5

Oral Oncology

Volumn 34, Issue 4, 1998, Pages 276-283

  McDonald, L A ^a   Walker, D M ^a   Gibbins, J R ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Keratin; Metastasis; Reverse transcriptase polymerase chain reaction; Squamous cell carcinoma

Indexed keywords

KERATIN; MESSENGER RNA;

ARTICLE; CANCER RISK; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE AMPLIFICATION; GENE EXPRESSION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRON; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TISSUE SPECIFICITY;

EID: 0031848005     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00098-5     Document Type: Article

References (33)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer 1993;54:594-606.
2. Macfarlane GJ, McCredie M, Coates M. Patterns of oral and pharyngeal cancer incidence in New South Wales, Australia. Journal of Oral Pathology and Oral Medicine 1994;23:241-245.
3. Macfarlane GJ, Sharp L, Porter S, Franceschi S. Trends in survival from cancers of the oral cavity and pharynx in Scotland: a clue as to why the disease is becoming more common? British Journal of Cancer 1996;73:805-808.
4. Strong EW, Spiro RH. Cancer of the oral cavity. In: Suen JY, Myers EN, editors. Cancer of the Head and Neck. New York: Churchill Livingstone, 1981. p. 304.
5. Shaha AR, Spiro RH, Shah JP, Strong EW. Squamous carcinoma of the floor of the mouth. American Journal of Surgery 1984;148:455-459.
6. Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW. Predictive value of tumour thickness in squamous carcinoma confined to the tongue and floor of the mouth. American Journal of Surgery 1986;152:345-350.
7. Shah JP, Anderson PE. Evolving role of modifications in neck dissection for oral squamous cell carcinoma. British Journal of Oral and Maxillofacial Surgery 1995;33:3-8.
8. Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994;74: 1595-1600.
9. International (Ludwig) breast cancer study group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-1668.
10. Byrne J, Waldron R, McAvinchey D, Dervan P. The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases. European Journal of Surgical Oncology 1987;13:409-411.
11. Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohistochemically identifiable tumour cells in lymph nodes of patients with completely resected esophageal cancer. New England Journal of Medicine 1997;337:1188-1194.
12. Schoenfeld A, Luqmani Y, Smith D, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Research 1994;54:2986-2990.
13. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Annals of Surgery 1994;220:768-774.
14. Deguchi T, Doi T, Ehara H, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Research 1993;53:5350-5354.
15. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
16. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. American Journal of Pathology 1996;148:649-656.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual, 2nd Edition. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989.
18. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry 1981;29:577-580.
19. Lersch R, Fuchs E. Sequence and expression of a type II keratin, K5, in human epidermal cells. Molecular and Cellular Biology 1988;8:486-493.
20. Morgan PR, Su L. Intermediate filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia. Oral Oncology, European Journal of Cancer 1994;30B:160-166.
21. Fechner RE, Mills SE. Larynx and pharynx. In: Sternberg SS, editor. Histology for Pathologists. New York: Raven Press, 1992. p. 443-55.
22. Krismann M, Todt B, Shröder J, et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. Journal of Clinical Oncology 1995;13:2769-2775.
23. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. Journal of Clinical Oncology 1994;12:475-482.
24. Bader BL, Jahn L, Franke WW. Low level expression of cytokeratin 8, 18, and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. European Journal of Cell Biology 1988;47:300-319.
25. Chelly J, Concordet J-P, Kaplan J-C, Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proceedings of the National Academy of Sciences of the United States of America 1989;86:2617-2621.
26. Sarkar G, Sommer SS. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science 1989;244:331-334.
27. Vaidya MM, Borges AM, Pradhan SA, Bhisey AN. Cytokeratin expression in squamous cell carcinomas of the tongue and alveolar mucosa. Oral Oncology, European Journal of Cancer 1996; 32B:333-336.
28. Vaidya MM, Borges AM, Pradhan SA, Rajpal RM, Bhisey AN. Altered keratin expression in buccal mucosal squamous cell carcinoma. Journal of Oral Pathology and Oral Medicine 1989;18:282-286.
29. Paterson IC, Eveson JW, Prime SS. Molecular changes in oral cancer may reflect aetiology and ethnic origin. Oral Oncology, European Journal of Cancer 1996;32B:150-153.
30. Marley JJ, Robinson PA, Hurne WJ. Expression of human cytokeratin 14 in normal, premalignant and malignant oral tissue following isolation by plaque hybridisation. Oral Oncology, European Journal of Cancer 1994;30B:305-311.
31. Paine ML, Gibbins JR, Chew KE, Demetriou A, Kefford RF. Loss of keratin expression in anaplastic carcinoma cells due to post-transcriptional down-regulation acting in trans. Cancer Research 1992;52:6603-6611.
32. Su L, Morgan PR, Lane EB. Protein and mRNA expression of simple epithelial keratins in normal, dysplastic and malignant oral epithelia. American Journal of Pathology 1994;145:1349-1357.
33. Traweek ST, Liu J, Battifora H. Keratin gene expression in non-epithelial tissues. American Journal of Pathology 1993;142:1111-1118.